Tatiana Yakovleva

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Cardiovascular Risk Factors

Top Venues

Diabetes, obesity & metabolism

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Victor Sokolov, Tatiana Yakovleva, Leonid A Stolbov, Robert C Penland, David Boulton, Joanna Parkinson, Weifeng Tang
A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes. CPT: pharmacometrics & systems pharmacology (2023)
Victor Sokolov, Tatiana Yakovleva, Leonid A Stolbov, Robert C Penland, David Boulton, Joanna Parkinson, Weifeng Tang
A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes. CPT: pharmacometrics & systems pharmacology (2023)
Millie Shah, Leonid A Stolbov, Tatiana Yakovleva, Weifeng Tang, Victor Sokolov, Robert C Penland, David W Boulton, Joanna Parkinson
A model-based approach to investigating the relationship between glucose-insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes. Diabetes, obesity & metabolism 23 (4) (2021)
Tatiana Yakovleva, Victor Sokolov, Lulu Chu, Weifeng Tang, Peter J Greasley, Helena Peilot Sjögren, Susanne Johansson, Kirill Peskov, Gabriel Helmlinger, David W Boulton, Robert C Penland
Comparison of the urinary glucose excretion contributions of SGLT2 and SGLT1: A quantitative systems pharmacology analysis in healthy individuals and patients with type 2 diabetes treated with SGLT2 inhibitors. Diabetes, obesity & metabolism 21 (12) (2019)
Victor Sokolov, Tatiana Yakovleva, Shinya Ueda, Joanna Parkinson, David W Boulton, Robert C Penland, Weifeng Tang
Urinary glucose excretion after dapagliflozin treatment: An exposure-response modelling comparison between Japanese and non-Japanese patients diagnosed with type 1 diabetes mellitus. Diabetes, obesity & metabolism 21 (4) (2018)